Reports of Patent, Design, and Trade Mark Cases, Issues 1-5; Issues 8-13Published at the Patent Office Sales Branch, 2003 - Industrial property |
From inside the book
Results 1-3 of 82
Page 6
... basis that the addition of the word KING did not avoid infringement of the mark for the plain tab . The counterclaim ... basis for which and his conclusion thereon is clear from the following passage in his judgment [ page 378 ] : " At ...
... basis that the addition of the word KING did not avoid infringement of the mark for the plain tab . The counterclaim ... basis for which and his conclusion thereon is clear from the following passage in his judgment [ page 378 ] : " At ...
Page 85
... basis upon which Amgen could perfectly properly contend that recombinant EPO could be distinguished from prior art EPO on the grounds of carbohydrate content . Even after error ( c ) , and with it the whole of the second paragraph of ...
... basis upon which Amgen could perfectly properly contend that recombinant EPO could be distinguished from prior art EPO on the grounds of carbohydrate content . Even after error ( c ) , and with it the whole of the second paragraph of ...
Page 308
... basis of earlier rights . Shortly before the opposition hearing , the applicant voluntarily offered to amend its application by restricting the specified goods and services . The hearing of the opposition , which was not attended by the ...
... basis of earlier rights . Shortly before the opposition hearing , the applicant voluntarily offered to amend its application by restricting the specified goods and services . The hearing of the opposition , which was not attended by the ...
Other editions - View all
Common terms and phrases
ALBERTA FERRETTI amendment Amgen amino acid Appointed Person Arsenal FC Arsenal Football Club burner cell claim 19 claimant colour common general knowledge contact lens CooperVision Court of Appeal cross-examination Davies decision defendants Directive distinctive character DNA sequence dots earlier trade mark effect erythropoietin European Patent evidence filed gene hearing officer High Court Inc v Transkaryotic infringement Integer inventive step iris section issue judge judgment Kirin-Amgen Inc lenses likelihood of confusion Ltd's Trade Mark Marks Act 1994 Meneghetti non-use opponent paragraph numbers paras Patent Office Philips Electronics NV Plc v Reed prior art priority date protein question Quickfit reason Reed Business Information referred registered trade mark registrar relation relevant Remington Consumer Products revocation shape Silverleaf specification submissions Sweet & Maxwell Synthon third party TORRES TRADE MARK 2003 Trade Mark Application trade mark proprietor Trade Marks Act Transkaryotic Therapies Inc uEPO United Kingdom word